Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001574774-19-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-07 18:12:26
Reporting Period:
2019-05-03
Accepted Time:
2019-05-07 18:12:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1574774 Biotelemetry Inc. BEAT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181032 E Kirk Gorman 1000 Cedar Hollow Rd. Suite 102
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-03 5,518 $17.67 178,833 No 4 M Direct
Common Stock Disposition 2019-05-03 5,518 $53.69 173,315 No 4 S Direct
Common Stock Acquisiton 2019-05-03 3,077 $0.00 176,392 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2019-05-03 5,518 $0.00 5,518 $17.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-08 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.53 to $53.93, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  2. Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date.
  3. The stock options vested in four equal quarterly installments, which began on June 30, 2009. The options were fully exercisable on March 31, 2010.